课题基金 / 基金详情

Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer

Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
压力和增殖状态影响 MicroRNA 介导的癌症调节
批准号:
8826043
负责人:
Phillip A Sharp
金额:
$47.74万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-14 至 2016-03-31

项目摘要

项目成果

Phillip A Sharp的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):MicroRNAs被预测调节人类细胞中的大多数基因,并且在不同的癌细胞中,一些MicroRNAs的过表达和表达缺失与恶性表型相关。miRNA活性的降低是最常见的观察结果,可能对肿瘤细胞的可塑性进行分化状态之间的转换和在不同的生态位中生长很重要。本提案的主要目标之一是研究mirna亚群在促进肿瘤细胞特性中的功能,特别是这些细胞对应激反应的能力。由于DNA损伤、未折叠蛋白的存在、生存信号的剥夺和氧气的存在,许多治疗癌症的方法都会引起应激。我们发现,miRNA调控的缺失使许多类型的癌细胞对这些应激因子过敏。例如,在许多癌细胞中,删除Dicer(合成大多数miRNAs所需的双链内切酶)会产生活细胞,这些活细胞实际上可以在异种移植物挑战中产生肿瘤,但对应激敏感。没有Dicer- null的人类癌症尚未被观察到,但最近对几种不同类型的人类癌症中的单倍体Dicer基因进行测序发现了一个特定的点突变,该突变使一个RNase III结构域失活。这表明这些肿瘤细胞被强烈地选择为mirna亚群的丢失和其他mirna的保留。表达这种突变的Dicer的细胞表达let-7 miRNA家族有缺陷,但表达其他miRNA接近正常水平。这项建议的四个具体目标是在过去四年的进展基础上建立起来的。首先,我们将进一步研究Dicer null细胞中靶向Argonaute 2 (Ago2)特异性RNA序列的因子的性质。我们还将研究这种靶向如何通过共结合miRNA提高沉默的定量水平。其次,我们将描述由Dicer特定功能突变产生的mirna亚群,并确定这些亚群的表达对肿瘤表型和应激反应的影响。第三,我们将测试Dicer抑制剂是否应该被视为药物开发的一个有希望的目标,以联合化疗治疗癌症。第四,我们将研究Argonaute的功能,它对mirna合成缺陷的胚胎干细胞的生存至关重要,即Dicer无效。
英文摘要
DESCRIPTION (provided by applicant): MicroRNAs are predicted to regulate a majority of genes in human cells and both overexpression and loss of expression of some miRNAs are correlated with malignant phenotypes in different cancer cells. A decrease in miRNA activity is most commonly observed and may be important for the plasticity of tumor cells to undergo transitions between differentiation states and to grow in different niches. One of the major objectives of this proposal is to investigate the functions of subsets of miRNAs in contributing to the properties of tumor cells and specifically to the ability of these cells to respond to stress. Many therapeutic treatments of cancer induce stress due to DNA damage, presence of unfolded proteins, deprivation of survival signals, and oxygen. We found that loss of miRNA regulation renders many types of cancer cells hypersensitive to such stress agents. For example, deletion of Dicer, a double strand endonuclease required for synthesis of most miRNAs, in many cancer cells yields viable cells that can in fact produce tumors in xenograft challenges but are hypersensitive to stress. Dicer- null human cancers have not been observed but recently sequencing of a haploid Dicer gene in several different types of human cancers identified a specific point mutation that inactivated one RNase III domain. This indicates that these tumor cells are being strongly selected for loss of a subset of miRNAs and for retention of other miRNAs. Cells expressing this mutant Dicer are defective for expression of the let-7 miRNA family but express near normal levels of other miRNAs. The four specific aims of this proposal build from progress over the past four years. First, we will further investigate the nature of factors targeting Argonaute 2 (Ago2) to specific RNA sequences in Dicer null cells. We will also investigate how this targeting enhances the quantitative level of silencing by co-binding miRNA. Second, we will characterize the subset of miRNAs generated by mutations of specific functions of Dicer and determine the consequences of expression of these subsets on tumor phenotype and response to stress. Third we will test if an inhibitor of Dicer should be considered as a promising objective for drug development to treat cancer in conjunction with chemotherapy. And fourth, we will investigate the function of Argonaute that is essential for viability in embryonic stem cells defective for synthesis of miRNAs, i.e. null for Dicer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanoformulations for siRNA Delivery to Ovarian Cancer
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
TREATMENT OF CANCER WITH siRNA DELVIERED BY NANOPARTICLES
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
海外基金